Gemcitabine + Nab-Paclitaxel for advanced pancreatic cancer: A retrospective audit of dose intensity, toxicity and efficacy

A. Mant, R. Wong, J. McKendrik, M. Lee

Research output: Contribution to journal › Meeting Abstract › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{66cc4d8264b0486c8bbeeac1115d01b4,

title = "Gemcitabine + Nab-Paclitaxel for advanced pancreatic cancer: A retrospective audit of dose intensity, toxicity and efficacy",

author = "A. Mant and R. Wong and J. McKendrik and M. Lee",

year = "2017",

month = nov,

doi = "10.1093/annonc/mdx660.036",

language = "English",

volume = "28",

pages = "x68",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "Supplement 10",

}

TY - JOUR

T1 - Gemcitabine + Nab-Paclitaxel for advanced pancreatic cancer

T2 - A retrospective audit of dose intensity, toxicity and efficacy

AU - Mant, A.

AU - Wong, R.

AU - McKendrik, J.

AU - Lee, M.

PY - 2017/11

Y1 - 2017/11

U2 - 10.1093/annonc/mdx660.036

DO - 10.1093/annonc/mdx660.036

M3 - Meeting Abstract

SN - 0923-7534

VL - 28

SP - x68

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 10

ER -